AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise. The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).
Learn more about the comment process
AMIA responses are arranged by Federal Agency and Congressional Committee.
AMIA responds to Request for Information (RFI) on the National Institutes of Health (NIH) Draft
Public Access Policy. Areas AMIA commented on were embargo periods and publication costs, supplemental materials, and investigator rights. Read full comment letter below.
AMIA and 30 supporting organizations’ position that the SOC manual update must include dedicated “clinical informatics” codes under each profession in the Healthcare Practitioners and Technical Occupations. Read the full proposal below.
AMIA joined with the Patient ID Now coalition in response to a Congressional RFI regarding feedback on ensuring Congress meets the goals of the 21st Century Cures Act and Cures 2.0. The coalition commented on issues concerning patient matching, updating health IT certification requirements, and promoting interoperability requirements. Read the […]
The American Medical Informatics Association (AMIA) appreciates the Office of the National Coordinator for Health Information Technology (ONC) giving the opportunity to comment on the 2024-2030 Federal Health IT Strategic Plan. AMIA members have been innovators and leading implementors of health information technology (IT). AMIA is a longstanding advocate for […]
AMIA received a request for information (RFI) from House of Representative Ami Bera (D- California District 6) regarding the current state of AI in health care. Aspects in the RFI include how extensively is AI implemented in health institutions, existing evidence regarding efficacy and accuracy of AI-driven health care solutions […]
Thank you for the opportunity to submit comments to the Food and Drug Administration’s (FDA) draft guidance “Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products.” As the leading organization of professionals working with healthcare data and protected health information (PHI), the American […]
On behalf of the undersigned organizations, we urge you to reject the inclusion of outdated rider language in Section 510 of the Fiscal Year 2025 Labor, Health and Human Services, and Education and Related Agencies (Labor-HHS) Appropriations bill that prohibits the US Department of Health and Human Services (HHS) from […]
Thank you for the opportunity to submit comments to the National Security Division of the Department of Justice advanced notice for proposed rulemaking (ANPRM) join provisions regarding access to Americans’ bulk sensitive personal data and government-related data by countries of concern. As the leading organization of professionals working with healthcare data […]
AMIA appreciates ONC’s efforts to solicit feedback on data collection for future iterations of the United States Core Data for Interoperability (USCDI). AMIA reflected on USCDI v5 Draft to recommend edits to USCDI v5 final version. Below are the Data Classes and Elements AMIA provided feedback:
Data Classes